[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@SiemprePulpo The Octopus Investing
The Octopus Investing posts on X about $nvo, $jmt, $lonn, $340m the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX +71%
- X Year XXXXXXX +237%
Mentions: X #
- X Week X -XX%
- X Month XX -XX%
- X Months XXX +98%
- X Year XXX +113%
Followers: XXXXX #
- X Week XXXXX +0.05%
- X Month XXXXX +0.40%
- X Months XXXXX +65%
- X Year XXXXX +175%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence finance XXXX% stocks XXXX% countries XXXX% cryptocurrencies XXXX%
Social topic influence $nvo #47, $jmt #1, $lonn 0.52%, $340m 0.52%, $21b 0.52%, poland 0.52%, $dnpwa 0.52%, $eurwa 0.52%, investment 0.52%, $lss XXXX%
Top accounts mentioned or mentioned by @drcm4t @paulcerro @mdbbolsa @joinyellowbrick @investseekers @zissoucapital @stonkmetal @investordotdev @invesquotes @valueinves12771 @kuxing86 @mikelgoiko68816 @researchitgg @labinversion @agnombela @vanguardeconomy @logos88 @evfcfaddict @benzg24 @himshouse
Top assets mentioned Novo-Nordisk (NVO) Lossless (LSS) Danaher Corporation (DHR) Hims & Hers Health, Inc. (HIMS)
Top Social Posts #
Top posts by engagements in the last XX hours
"Lonza Group AG $LONN is up +6.5% this morning on its H1 2025 results: 🔹Revenue: +19.0% at CER 🔹CDMO revenue: +23.1% at CER 🔹 Utilization improvement despite weaker CGT & microbial demand 🔹New facilities ramp-up within schedule 🔹Guidance raised: +1% both in sales & EBITDA Looking at positive results in pharma glass packaging manufacturers CROs & CDMOs results biotech demand looks to be finally back 😎"
X Link @SiemprePulpo 2025-07-23T08:27Z 1996 followers, 3552 engagements
"🚨 BREAKING $NVO expands it's rare diseases portfolio by acquiring Omeros' Ziltenibart (OMS906) asset a selective MASP-3 inhibitor for PNH and kidney diseases. Price: $340M + milestones up to $2.1B + royalties. I thought the plan was to focus in diabetes & obesity 🤔"
X Link @SiemprePulpo 2025-10-15T13:06Z 1996 followers, 1107 engagements
"Market consolidation is happening in Poland. That would eventually lead to only the best players prevailing and the returns increasing due to less aggressive competition. Good for $DNP.WA"
X Link @SiemprePulpo 2025-09-18T10:16Z 1996 followers, XXX engagements
"Anyone has a long/short investment thesis on Lectra $LSS"
X Link @SiemprePulpo 2025-09-16T15:51Z 1996 followers, XXX engagements
"We just hit XXX subs on my 🐝hiiv 📬letter Some of the content you can find there covers the following companies: 🔸Jernimo Martins $JMT 🔸Pandora $PNDORA 🔸Novo Nordisk $NVO 🔸Lonza $LONN.SW 🔸Hims&Hers $HIMS 🔸Danaher $DHR 🔸Theon International $THEON Big props to all of you for the supportlets keep this growth rolling 😎"
X Link @SiemprePulpo 2025-03-31T08:36Z 1996 followers, 4790 engagements
"Full $PNDORA.CO earnings review published today. After last friday's -XX% stock price drop today I am sharing with you: 🔸Financial statements review 🔸Main KPIs discussion 🔸Highlights from management call 🔸Risks revision Check my profile for more👤"
X Link @SiemprePulpo 2025-08-18T18:04Z 1996 followers, 1796 engagements